monoclon
antibodi
mab
essenti
tool
mani
diagnost
applic
research
investig
addit
mab
becom
ideal
therapeut
reagent
mani
diseas
well
establish
treatment
cancer
autoimmun
disord
infecti
diseas
mani
technolog
exist
gener
mab
research
therapeut
purpos
gener
research
purpos
murin
mab
obtain
hybridoma
technolog
base
fusion
b
cell
exampl
deriv
immun
mice
myeloma
cell
way
mab
almost
antigen
creat
direct
therapeut
use
murin
mab
human
limit
high
incid
harm
immun
respons
murin
foreign
protein
murin
antibodi
lack
suffici
effector
function
allevi
limit
murin
mab
reengin
chimer
human
technolog
murin
constant
framework
region
replac
human
sequenc
altern
human
mab
recov
hybridoma
b
cell
line
deriv
immunoglobulin
ig
transgen
mice
complet
partial
human
antibodi
repertoir
one
drawback
ig
transgen
mous
system
precis
imit
human
immun
respons
effect
murin
genet
background
antigen
process
b
cell
regul
result
recov
antibodi
might
display
precis
specif
natur
occur
antibodi
human
despit
drawback
major
approv
fulli
human
antibodi
today
deriv
ig
transgen
mous
system
overcom
issu
murin
system
strategi
engin
mab
creat
intact
human
immun
system
design
includ
human
hybridoma
technolog
review
email
address
thomastil
morphosyscom
immort
human
b
cell
transform
epsteinbarr
viru
ebv
one
major
advantag
method
allow
isol
nativ
human
mab
preserv
natur
vh
vl
pair
method
howev
gener
unsuit
comprehens
screen
larg
antibodi
repertoir
highli
select
ineffici
fusion
transform
event
spite
improv
method
yield
neutral
mab
exampl
influenza
viru
sar
corona
viru
addit
way
creat
select
mab
includ
combinatori
display
technolog
like
phage
yeast
mammalian
cell
display
phage
display
success
employ
screen
larg
antibodi
repertoir
isol
mab
virtual
antigen
interest
combinatori
display
technolog
also
allow
vitro
affin
matur
select
antibodi
one
drawback
howev
usual
reli
random
combin
thu
like
unnatur
vh
vl
antibodi
pair
thought
import
antibodi
develop
maintain
origin
vh
vl
pair
exist
human
b
cell
effici
strategi
design
base
direct
amplif
vh
vl
region
encod
gene
singl
human
b
cell
subsequ
express
cell
cultur
system
facilit
rapid
screen
detect
singl
cell
secret
antibodi
desir
reactiv
profil
larg
popul
primari
b
cell
cellbas
microarray
microengrav
techniqu
appli
singl
b
cell
antibodi
approach
harbor
potenti
isol
function
mab
reactiv
conform
determin
present
predominantli
vivo
difficult
emul
vitro
strategi
straightforward
requir
rel
cell
number
high
effici
obtain
specif
mab
rapid
way
balanc
downsid
need
adequ
human
donor
limit
certain
target
molecul
follow
paragraph
describ
basic
concept
singl
b
cell
antibodi
technolog
use
basic
research
select
antigenspecif
mab
depend
research
applic
singl
b
cell
isol
perform
either
random
way
antigenselect
manner
peripher
blood
lymphoid
tissu
exampl
bone
marrow
random
b
cell
isol
procedur
cell
pick
micromanipul
laser
captur
microdissect
fluorescenceactiv
cell
sort
fac
describ
altern
select
antigenspecif
b
cell
demonstr
use
antigenco
magnet
bead
fluorochromelabel
antigen
via
multiparamet
fac
hemolyt
plaqu
assay
fluoresc
foci
method
furthermor
cellbas
microarray
chip
system
establish
highthroughput
screen
mab
secret
singl
antibodi
produc
cell
major
advantag
fac
technolog
applic
cell
sort
clearli
distinguish
term
stage
develop
differenti
base
upon
express
pattern
specif
cell
surfac
marker
gener
b
cell
stage
sort
classswitch
memori
b
cell
antibodysecret
cell
asc
ie
plasmablast
plasma
cell
special
interest
obtain
relev
mab
bear
somat
mutat
b
cell
antigen
receptor
bcr
high
affin
exampl
igg
memori
b
cell
reactiv
recombin
trimer
antigen
success
select
patient
hiv
use
fluoresc
label
contrast
asc
specif
vaccin
sort
without
antigen
label
post
immun
effici
recoveri
specif
mab
donor
immun
respons
must
assess
method
exampl
determin
frequenc
asc
peripher
blood
use
enzymelink
immunospot
techniqu
elispot
singl
cell
isol
addit
highthroughput
method
gener
lead
effici
identif
b
cell
desir
specif
ig
gene
clone
one
specif
method
soft
lithograph
method
microengrav
per
screen
one
hundr
thousand
polyclon
b
cell
stimul
mitogen
develop
asc
deposit
individu
array
microscal
well
chip
array
use
print
correspond
protein
array
wherebi
element
contain
antibodi
secret
one
singl
b
cell
antibodi
microarray
screen
fluoresc
label
antigen
interest
map
correspond
cell
manual
retriev
well
micromanipul
subsequ
analyz
clonal
expans
singl
cell
revers
transcriptionpolymeras
chain
reaction
rtpcr
similar
approach
immunospot
array
assay
chip
isaac
method
establish
muraguchi
group
microengrav
technolog
singl
asc
place
microwel
chip
chip
surfac
coat
antiig
antibodi
antibodi
secret
one
individu
asc
captur
surfac
around
well
bind
biotinyl
antigen
specif
antibodi
allow
detect
fluorescenceconjug
streptavidin
microengrav
isaac
offer
compel
advantag
earli
rapid
identif
cell
secret
antibodi
high
affin
specif
antigen
interest
polyclon
mixtur
furthermor
techniqu
simplifi
screen
multipl
antigen
allow
select
differ
clone
distinct
specif
construct
complementari
dna
cdna
singl
b
cell
provid
unbias
approach
simultan
analysi
express
igh
igl
chain
gene
usual
singl
cell
cdna
synthesi
perform
origin
devic
use
cell
deposit
cell
lysi
eg
plate
assur
conveni
handl
larg
number
sampl
minim
risk
crosscontamin
notabl
distinct
b
cell
type
show
differ
amount
specif
ig
gene
mrna
transcript
exampl
compar
memori
b
cell
asc
contain
rel
larg
amount
ig
gene
transcript
therebi
facilit
specif
ig
gene
amplif
usual
fulllength
ig
gene
transcript
amplifi
nest
seminest
rtpcr
wherebi
rt
might
perform
onestep
reaction
first
round
pcr
typic
forward
primer
mix
complementari
correspond
igh
igl
v
gene
leader
sequenc
singl
revers
primer
specif
constant
region
sequenc
use
necessari
exampl
isotyp
independ
cell
sort
perform
mix
revers
primer
use
amplif
igh
chain
differ
constant
region
second
round
nest
primer
primer
mix
use
increas
sensit
specif
furthermor
restrict
site
subsequ
clone
step
incorpor
amplicon
step
altern
linear
express
cassett
assembl
directli
transfect
mammalian
cell
vitro
express
amplifi
ig
gene
strategi
link
rearrang
igh
igl
chain
gene
amplif
also
explor
exampl
meijer
et
al
develop
multiplex
singl
cell
rtpcr
approach
combin
amplifi
igh
igl
chain
product
pcr
overlap
extens
step
join
dna
fragment
subsequ
clone
appropri
express
vector
mab
product
although
singl
cell
rtpcr
method
straightforward
everi
protocol
amplifi
function
igh
igl
v
gene
limit
design
set
forward
primer
use
method
allow
amplif
unknown
end
mrna
rapid
amplif
cdna
end
race
technolog
although
standard
race
techniqu
unsuit
synthes
cdna
singl
cell
usual
small
quantiti
mrna
present
improv
protocol
demonstr
suitabl
isol
ig
gene
singl
b
cell
promis
effici
regardless
ig
gene
amplif
strategi
use
singl
cell
ig
gene
transcript
inform
encod
specif
antibodi
subsequ
rescu
sequenc
rearrang
v
j
gene
segment
easili
identifi
analyz
presenc
mutat
insert
delet
use
variou
databas
igblast
search
engin
ncbi
websit
http
wwwncbinlmnihgovigblast
determin
reactiv
profil
biophys
characterist
antibodi
fragment
thereof
protein
express
purifi
test
variou
assay
conveni
cellbas
microarray
system
reactiv
screen
perform
ig
gene
clone
analyz
correspond
antibodi
detail
howev
molecular
ig
gene
clone
step
indispens
largescal
amount
protein
need
common
choic
express
system
bacteri
system
eg
escherichia
coli
transient
andor
stabl
mammalian
cell
system
eg
hek
cho
cell
e
coli
clone
ig
gene
typic
express
antigenbind
fragment
fab
wherea
mammalian
cell
express
complet
igg
format
classic
mous
human
antibodi
repertoir
analys
cellbycel
basi
significantli
increas
knowledg
gener
b
cell
immunolog
concept
initi
ig
gene
singl
b
cell
studi
genom
level
singl
cell
pcr
elucid
molecular
basi
ig
gene
rearrang
allel
exclus
event
next
step
strategi
develop
synthesi
cdna
singl
b
cell
facilit
unbias
descript
mous
human
antibodi
repertoir
substanti
advanc
understand
express
human
antibodi
repertoir
made
nussenzweig
group
pioneer
investig
defin
b
cell
specif
b
cell
develop
differenti
analysi
recombin
mab
clone
individu
b
cell
healthi
individu
reveal
major
newli
gener
b
cell
bone
marrow
selfreact
two
checkpoint
one
bone
marrow
anoth
peripheri
select
selfreact
b
cell
develop
character
alter
b
cell
repertoir
patient
defici
innat
immun
pathway
meffr
group
suggest
pathway
requir
remov
selfreact
immatur
b
cell
base
analysi
b
cell
autoimmun
patient
propos
failur
establish
toler
checkpoint
associ
develop
system
lupu
erythematosu
sle
rheumatoid
arthriti
studi
describ
third
checkpoint
select
selfreact
igm
memori
b
cell
differenti
surprisingli
though
later
develop
igg
memori
b
cell
frequent
express
selfreact
antibodi
healthi
donor
addit
approach
elucid
basic
b
cell
biolog
system
evolv
isol
valuabl
mab
immun
donor
potenti
therapeut
use
applic
epitop
discoveri
vaccin
design
ethic
concern
human
expos
antigen
therefor
clear
adequ
donor
avail
asc
memori
b
cell
antibodi
reactiv
antigen
interest
recov
particularli
vaccin
human
subject
follow
day
immun
ideal
candid
obtain
antibodi
immun
system
usual
mount
broad
humor
respons
immun
agent
mab
reactiv
multipl
epitop
immunogen
may
avail
elegantli
demonstr
wilson
lab
engin
human
antibodi
specif
influenza
viru
vaccin
asc
isol
vaccin
donor
day
immun
interestingli
mani
asc
purifi
timepoint
influenza
specif
recoveri
asc
peripher
blood
peak
immun
respons
essenti
cell
rapidli
declin
bloodstream
migrat
bone
marrow
becom
longliv
plasma
cell
maintain
humor
memori
lifetim
altern
memori
b
cell
isol
peripher
blood
natur
infect
vaccin
human
even
month
year
antigen
exposur
although
exact
correl
antigenspecif
memori
b
cell
frequenc
serum
antibodi
titer
still
clarifi
human
determin
antigenspecif
serum
antibodi
titer
help
identifi
appropri
donor
exampl
scheid
et
al
character
b
cell
memori
respons
hiv
six
infect
patient
broadli
hiv
neutral
serum
antibodi
studi
mab
isol
singl
hivenvelop
bind
memori
b
cell
show
specif
bind
recombin
antigen
although
none
isol
mab
found
broadli
neutral
across
variou
strain
hiv
combin
individu
antibodi
reveal
broad
neutral
effect
similar
approach
produc
neutral
antibodi
reactiv
circul
isol
overal
find
provid
import
insight
immun
respons
hiv
indispens
rational
vaccin
design
strategi
furthermor
singl
cell
ig
gene
clone
reveal
kinet
divers
antibodi
respons
tetanu
toxoid
ig
gene
repertoir
antirhesusdspecif
b
cell
addit
recent
use
cellbas
microarray
mab
hepat
b
surfac
antigen
prepar
character
overal
studi
demonstr
versatil
singl
b
cell
antibodi
approach
product
valuabl
antigenspecif
antibodi
last
decad
singl
b
cell
antibodi
technolog
becom
attract
approach
sampl
antigenexperienc
antibodi
repertoir
gener
vivo
method
prove
use
evalu
basic
b
cell
biolog
concept
health
autoimmun
furthermor
valuabl
mab
isol
vaccin
natur
immun
donor
patient
autoimmun
diseas
gener
mab
recov
singl
b
cell
antibodi
technolog
may
use
reagent
diagnost
pharmacokinet
studi
clinic
develop
major
applic
includ
prevent
infecti
diseas
passiv
immun
therapi
disord
current
medic
serum
igg
prepar
deeper
understand
neutral
mab
isol
immun
donor
also
help
rational
structurebas
vaccin
design
promis
effort
revers
vaccinolog
approach
current
made
hiv
research
applic
infecti
diseas
addit
futur
advanc
microfluid
platform
includ
pcr
cycl
combin
next
gener
sequenc
method
like
exceed
current
system
allow
highthroughput
ig
gene
sequenc
analys
individu
antibodi
repertoir
increas
avail
repertoir
singl
b
cell
antibodi
technolog
like
lead
develop
novel
mab
therapeut
